Greenwich LifeSciences Inc.
World Rank (Jan-05-2024)
19,932
Market Cap (Jan-05-2024)
0.135 Billion USD
World Rank (Jul-30-2023)
20,952
Market Cap (Jul-30-2023)
0.114 Billion USD
World Rank (Dec-25-2022)
18,390
Market Cap (Dec-25-2022)
0.187 Billion USD
World Rank (Jan-07-2022)
17,015
Market Cap (Jan-07-2022)
0.28 Billion USD
Company Profile
Greenwich LifeSciences, Inc. is a Public Clinical Stage Biopharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients have previously undergone surgery. The headquarters is in USA.
Company Website